Cornerstone Advisors, Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cornerstone Advisors, Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$1,0000.0%36
+50.0%
0.00%
Q2 2020$1,0000.0%24
-31.4%
0.00%
Q1 2020$1,000
-96.3%
35
-95.7%
0.00%
-100.0%
Q2 2019$27,000
+3.8%
813
+10.0%
0.00%0.0%
Q1 2019$26,000
+4.0%
739
-1.9%
0.00%
-25.0%
Q4 2018$25,000
-34.2%
7530.0%0.00%
-84.0%
Q3 2018$38,000
-15.6%
7530.0%0.02%
-19.4%
Q2 2018$45,000
+32.4%
7530.0%0.03%
+34.8%
Q1 2018$34,000
+17.2%
753
+1.9%
0.02%
+21.1%
Q4 2017$29,000
-3.3%
7390.0%0.02%
-9.5%
Q3 2017$30,000
-31.8%
739
-28.3%
0.02%
-16.0%
Q2 2017$44,000
+37.5%
1,0310.0%0.02%
+38.9%
Q1 2017$32,000
+23.1%
1,0310.0%0.02%
-18.2%
Q4 2016$26,000
+4.0%
1,0310.0%0.02%
+4.8%
Q3 2016$25,000
+19.0%
1,0310.0%0.02%0.0%
Q2 2016$21,000
+31.2%
1,0310.0%0.02%
+23.5%
Q1 2016$16,000
+14.3%
1,0310.0%0.02%
+13.3%
Q4 2015$14,0000.0%1,0310.0%0.02%
+25.0%
Q3 2015$14,0001,0310.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders